The Europe Structural Heart Devices Market was valued at $4800.1 Million in 2024 and projected to reach to $7398.8 Million by 2029, representing a compound annual growth rate of 9.0%. Europe's structural heart devices market is positioned for sustained expansion through 2029, driven by an aging population with increasing cardiovascular disease prevalence and growing adoption of catheter-based interventions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's rapidly aging demographic is significantly increasing the prevalence of structural heart conditions, creating sustained demand for innovative device solutions across the region's healthcare systems.
European healthcare providers are increasingly adopting minimally invasive interventional procedures, reducing patient recovery times and hospital stays while driving structural heart device utilization.
Europe's mature regulatory environment and CE marking requirements ensure high-quality device standards, fostering trust among healthcare providers and patients in structural heart interventions.
Germany, UK, Italy, and France represent the largest European markets, collectively accounting for the majority of regional structural heart device adoption and innovation.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | TAVR/TAVI PROCEDURES (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.5% from 2024 to 2029 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 16.32 (2024) |
| Revenue Forecast (Billions) | ~USD 25.69 (2029) |
| Segments Covered | Procedure, Type, Product, End User, Accessories |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 452.7 | 490.6 | 530.1 | 573.2 | 619.9 | 671.3 | 727.6 | 789.3 | 8.3 |
| HOSPITALS | 3161.4 | 3449.3 | 3751.3 | 4083.3 | 4445.6 | 4845.8 | 5287.1 | 5773.5 | 9 |
| OTHER ACCESSORIES | 429.1 | 472.5 | 518.7 | 569.8 | 626.1 | 688.8 | 758.5 | 836 | 10 |
| TOTAL | 4043.1 | 4412.4 | 4800.1 | 5226.3 | 5691.6 | 6206 | 6773.3 | 7398.8 | 9 |
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 51.1 | 55.1 | 59.2 | 63.6 | 68.4 | 73.7 | 79.4 | 85.7 | 7.7 |
| HOSPITALS | 362.3 | 393.1 | 425.3 | 460.4 | 498.5 | 540.4 | 586.4 | 636.8 | 8.4 |
| OTHER END USERS (CATH LABS, CARDIAC CENTERS) | 47.5 | 52.1 | 56.8 | 62.1 | 67.8 | 74.2 | 81.3 | 89 | 9.4 |
| TOTAL | 460.9 | 500.3 | 541.3 | 586.1 | 634.8 | 688.3 | 747.1 | 811.6 | 8.4 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 1149.7 Million |
| UK | USD 736.9 Million |
| France | USD 559.8 Million |
| Italy | USD 699.9 Million |
| Spain | USD 406.8 Million |
| Rest Of Europe | USD 433.3 Million |
Europe's structural heart devices market was valued at $4,800.1 million in 2024 and is projected to reach $7,398.8 million by 2029, growing at a 9.0% CAGR.
Europe's market growth is driven by an aging population, increasing prevalence of structural heart conditions, rising adoption of minimally invasive procedures, strong healthcare infrastructure, and established reimbursement pathways that support device innovation.
Major markets driving Europe's structural heart devices growth include Germany, France, Italy, Spain, and the United Kingdom, which benefit from advanced healthcare systems and high diagnostic capabilities.
Europe shows strong adoption of transcatheter and percutaneous devices for conditions such as atrial septal defects, patent foramen ovale closure, and valve repair or replacement, reflecting the region's preference for minimally invasive interventions.
Europe's 9.0% CAGR is slightly below the global 9.5% CAGR, reflecting the region's mature market status; however, Europe maintains higher adoption rates of advanced minimally invasive technologies and stronger regulatory oversight compared to emerging markets.
The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.
The following is a breakdown of the primary respondents:
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue.
As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the Structural heart devices market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.
Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.
Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report